BMRC vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BMRC exhibits mixed financial health with a Piotroski F-Score of 4/9 indicating stable but not strong fundamentals, and no available Altman Z-Score limits distress risk assessment. The stock trades at a significant premium to both Graham Number ($19.22) and intrinsic value ($17.40), supported by strong recent earnings growth (YoY EPS +67.9%) and improving profitability trends. However, elevated P/E of 44.78, declining technical trend (10/100), and a dangerously high payout ratio of 161.29% raise sustainability concerns. Analyst target of $30.40 suggests upside, but inconsistent quarterly beats and weak insider sentiment constrain bullish conviction.
JPM shows bullish fundamentals based on deterministic rules. Financial strength is weak (F-Score 2/9). Key strengths include strong valuation and growth metrics. Price trades at a 109.8% premium to fair value estimate ($140.21), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
BMRC vs JPM: Head-to-Head Comparison
This page compares Bank of Marin Bancorp (BMRC) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.